Are You Looking for a Top Momentum Pick? Why Xenon Pharmaceuticals (XENE) is a Great ChoiceZacks Investment Research • 01/23/20
Xenon Pharmaceuticals Announces Pricing of $60.0 Million Public Offering of Common SharesGlobeNewsWire • 01/23/20
Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2020 and Provides Corporate UpdateGlobeNewsWire • 01/13/20
Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/06/19
Xenon Pharmaceuticals to Present at the 2019 Cantor Global Healthcare ConferenceGlobeNewsWire • 09/25/19
Xenon Announces Appointment of Shelley McCloskey as Senior Vice President, Human ResourcesGlobeNewsWire • 09/17/19
Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/07/19
Xenon Pharmaceuticals (XENE) CEO Simon Pimstone on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/12/19